Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Cincinnati
mi
from
Cincinnati, OH
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
MetroHealth Med Ctr
mi
from
Cleveland, OH
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Ohio State University
mi
from
Columbus, OH
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Toledo
mi
from
Toledo, OH
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Toledo
mi
from
Toledo, OH
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Oregon Health and Science University
mi
from
Portland, OR
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Abington Memorial Hospital
mi
from
Abington, PA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Lankenau Institute for Medical Research
mi
from
Bryn Mawr, PA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Lankenau Institute for Medical Research
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Penn Stat-Hershey Medical Center (NINDS-CRC site)
mi
from
Hershey, PA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Penn Stat-Hershey Medical Center (NINDS-CRC site)
mi
from
Hershey, PA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Temple University
mi
from
Philadelphia, PA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Allegheny Singer Research Institute
mi
from
Pittsburgh, PA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Allegheny Singer Research Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Rhode Island Hospital
mi
from
Providence, RI
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Tennessee
mi
from
Memphis, TN
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Tennessee
mi
from
Memphis, TN
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Vanderbilt
mi
from
Nashville, TN
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Baylor Research Institute
mi
from
Dallas, TX
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Baylor Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Methodist Neurological Institute
mi
from
Houston, TX
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Methodist Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Texas
mi
from
San Antonio, TX
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Utah
mi
from
Salt Lake City, UT
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Vermont
mi
from
Burlington, VT
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Virginia
mi
from
Charlottesville, VA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Sentara Medical Group
mi
from
Norfolk, VA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Sentara Medical Group
mi
from
Norfolk, VA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Wisconsin
mi
from
Madison, WI
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Medical College of Wisconsin
mi
from
Milwaukee, WI
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Alabama
mi
from
Birmingham, AL
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Stanford University
mi
from
Palo Alto, CA
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Albany Medical Center
mi
from
Albany, NY
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
University of Texas Southwestern
mi
from
Dallas, TX
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Marshfield Clinic
mi
from
Marshfield, WI
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated:  1/6/2016
Flinders Medical Centre
mi
from
Bedford Park,
Insulin Resistance Intervention After Stroke Trial
Insulin Resistance Intervention After Stroke (IRIS) Trial
Status: Enrolling
Updated: 1/6/2016
Flinders Medical Centre
mi
from
Bedford Park,
Click here to add this to my saved trials
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
Phase I/II Study of SOD1 Inhibition by Pyrimethamine in Familial ALS
Status: Enrolling
Updated:  1/6/2016
Weill Cornell Medical Center/New York Presbyterian Hospital
mi
from
New York, NY
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
Phase I/II Study of SOD1 Inhibition by Pyrimethamine in Familial ALS
Status: Enrolling
Updated: 1/6/2016
Weill Cornell Medical Center/New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
Phase I/II Study of SOD1 Inhibition by Pyrimethamine in Familial ALS
Status: Enrolling
Updated:  1/6/2016
Methodist Neurological Institute
mi
from
Houston, TX
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
Phase I/II Study of SOD1 Inhibition by Pyrimethamine in Familial ALS
Status: Enrolling
Updated: 1/6/2016
Methodist Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
Phase I/II Study of SOD1 Inhibition by Pyrimethamine in Familial ALS
Status: Enrolling
Updated:  1/6/2016
Universitäts- und Rehabilitationskliniken Ulm
mi
from
Ulm,
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
Phase I/II Study of SOD1 Inhibition by Pyrimethamine in Familial ALS
Status: Enrolling
Updated: 1/6/2016
Universitäts- und Rehabilitationskliniken Ulm
mi
from
Ulm,
Click here to add this to my saved trials
Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy
Scrambler Therapy for the Treatment of Chemotherapy Induced Peripheral Neuropathy: An Open Access Trial
Status: Enrolling
Updated:  1/6/2016
The Mayo Clinic
mi
from
Rochester, MN
Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy
Scrambler Therapy for the Treatment of Chemotherapy Induced Peripheral Neuropathy: An Open Access Trial
Status: Enrolling
Updated: 1/6/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Phoenix Children's Hospital
mi
from
Phoenix, AZ
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Arkansas Children's Hospital
mi
from
Little Rock, AR
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Miller Children's Hospital
mi
from
Long Beach, CA
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Miller Children's Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Children's Hospital Central California
mi
from
Madera, CA
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Children's Hospital Central California
mi
from
Madera, CA
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Kaiser Permanente
mi
from
Oakland, CA
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Kaiser Permanente
mi
from
Oakland, CA
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Children's Hospital of Orange County
mi
from
Orange, CA
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
UCSF Benioff Children's Hospital / UCSF Benioff Children's Hospital
mi
from
San Francisco, CA
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
UCSF Benioff Children's Hospital / UCSF Benioff Children's Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Children's Hospital Colorado
mi
from
Aurora, CO
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Children's National Medical Center Center for Cancer & Blood Disorders
mi
from
Washington,
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Children's National Medical Center Center for Cancer & Blood Disorders
mi
from
Washington,
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Nemours Children's Clinic
mi
from
Jacksonville, FL
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
All Children's Hospital
mi
from
St. Petersburg, FL
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
All Children's Hospital
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated:  1/6/2016
Riley Hospital for Children, Indiana University
mi
from
Indianapolis, IN
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Status: Enrolling
Updated: 1/6/2016
Riley Hospital for Children, Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials